Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$1.34B |
| 2 |
NVIDIA
NVDA
|
+$546M |
| 3 |
Boeing
BA
|
+$405M |
| 4 |
Linde
LIN
|
+$405M |
| 5 |
Exxon Mobil
XOM
|
+$316M |
Top Sells
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.42B |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$319M |
| 3 |
Microsoft
MSFT
|
+$292M |
| 4 |
Accenture
ACN
|
+$277M |
| 5 |
Lam Research
LRCX
|
+$271M |
Sector Composition
| 1 | Technology | 26.07% |
| 2 | Healthcare | 13.09% |
| 3 | Financials | 11.54% |
| 4 | Consumer Discretionary | 10.68% |
| 5 | Industrials | 8.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Establishment Labs
ESTA
$1.09B
| $13M | ﹤0.01% |
192,191
-4,487
| -2% | -$304K |
|
1302
Titan Machinery
TITN
$451M
| $13M | ﹤0.01% |
427,204
+38,617
| +10% | +$1.18M |
|
1303
A-Mark Precious Metals
AMRK
$664M
| $13M | ﹤0.01% |
374,765
-45,732
| -11% | -$1.58M |
|
1304
Coeur Mining
CDE
$9.98B
| $13M | ﹤0.01% |
3,252,650
+1,929,873
| +146% | +$7.7M |
|
|
RVNC
1305
DELISTED
Revance Therapeutics, Inc.
RVNC
| $13M | ﹤0.01% |
402,282
-98,565
| -20% | -$3.17M |
|
1306
Fox Class B
FOX
$25.8B
| $12.9M | ﹤0.01% |
412,845
-2,804
| -0.7% | -$87.8K |
|
1307
Federated Hermes
FHI
$4.16B
| $12.9M | ﹤0.01% |
321,368
-87,247
| -21% | -$3.5M |
|
1308
Synovus
SNV
$7.18B
| $12.9M | ﹤0.01% |
418,153
+5,342
| +1% | +$165K |
|
|
GMS
1309
DELISTED
GMS Inc
GMS
| $12.9M | ﹤0.01% |
222,403
-29,696
| -12% | -$1.72M |
|
1310
Globus Medical
GMED
$7.93B
| $12.9M | ﹤0.01% |
227,117
+40,935
| +22% | +$2.32M |
|
1311
Live Oak Bancshares
LOB
$1.67B
| $12.9M | ﹤0.01% |
527,452
+230,373
| +78% | +$5.61M |
|
1312
H.B. Fuller
FUL
$3.33B
| $12.8M | ﹤0.01% |
187,556
-2,378
| -1% | -$163K |
|
1313
iRhythm Technologies
IRTC
$5.78B
| $12.8M | ﹤0.01% |
103,359
-18,006
| -15% | -$2.23M |
|
1314
Guidewire Software
GWRE
$21.3B
| $12.8M | ﹤0.01% |
156,085
-888
| -0.6% | -$72.9K |
|
1315
Nordic American Tanker
NAT
$669M
| $12.8M | ﹤0.01% |
3,230,845
-485,407
| -13% | -$1.92M |
|
1316
Avis
CAR
$5.47B
| $12.8M | ﹤0.01% |
65,672
-585
| -0.9% | -$114K |
|
1317
CTS Corp
CTS
$1.23B
| $12.7M | ﹤0.01% |
257,386
-15,489
| -6% | -$766K |
|
|
NXGN
1318
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $12.7M | ﹤0.01% |
730,969
+116,872
| +19% | +$2.03M |
|
1319
White Mountains Insurance
WTM
$4.54B
| $12.7M | ﹤0.01% |
9,224
-205
| -2% | -$282K |
|
1320
Perrigo
PRGO
$3.06B
| $12.7M | ﹤0.01% |
353,844
-274,825
| -44% | -$9.86M |
|
1321
Zions Bancorporation
ZION
$8.62B
| $12.7M | ﹤0.01% |
423,476
-78,108
| -16% | -$2.34M |
|
1322
RXO
RXO
$2.71B
| $12.7M | ﹤0.01% |
645,042
+74,336
| +13% | +$1.46M |
|
|
AZPN
1323
DELISTED
Aspen Technology Inc
AZPN
| $12.7M | ﹤0.01% |
55,339
-2,264
| -4% | -$518K |
|
1324
Agilon Health
AGL
$443M
| $12.7M | ﹤0.01% |
533,088
+26,973
| +5% | +$641K |
|
1325
Enova International
ENVA
$2.88B
| $12.6M | ﹤0.01% |
284,690
-53,842
| -16% | -$2.39M |
|